选项

处方审核助手

{:__('collect %s',处方审核助手)}

利用AI技术辅助药师进行处方审核,识别潜在的药物相互作用、剂量错误及禁忌症,提升用药安全与效率。

提示内容 复制 复制

Act as a senior clinical pharmacist to conduct a comprehensive review of the provided patient prescription data. First, extract key patient demographics, diagnosis, and all prescribed medications with their respective dosages. Second, cross-reference these details against current clinical guidelines and drug monographs to identify potential drug-drug interactions, contraindications, and dosage appropriateness relative to the patient's renal or hepatic function. Third, evaluate the rationale for any off-label uses and assess potential adverse effects. Finally, present your findings in a structured list, highlighting any safety concerns, recommended dosage adjustments, or areas requiring further clinical verification, ensuring the output is actionable and prioritizes patient safety.

复制 复制

请模拟资深临床药师的角色,对提供的患者处方信息进行深度审核。首先,提取患者基本信息、诊断结果及所有拟用药物名称与剂量。其次,基于最新临床指南和药品说明书,逐一检查药物之间的相互作用风险、是否存在配伍禁忌以及是否符合患者的肝肾功能状态。接着,重点排查超说明书用药的合理性及潜在不良反应。最后,以清晰的结构化列表形式输出审核结果,明确指出任何发现的安全隐患、剂量调整建议或需要进一步确认的疑点,确保最终给出的建议具有高度的临床可操作性和安全性。

复制 复制
评论 (0)
0/300

推荐

处方审核助手
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, contraindication matching, and dosage appropriateness. Cross-reference with the patient's medical history and allergy records to flag any potential risks and provide optimization suggestions aligned with the latest clinical guidelines, ensuring the safety and efficacy of the medication regimen.
处方审核助手
Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, checking for incompatibilities, verifying if dosages align with the patient's age and renal/hepatic function, and ensuring no contraindications are violated. List all identified risks and provide optimization suggestions or alternatives based on the latest clinical guidelines to ensure medication safety and regulatory compliance.
处方审核助手
Act as a senior clinical pharmacist to review the following prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Aspirin 100mg once daily, and Ibuprofen 400mg three times daily. Focus on evaluating the renal risks of NSAIDs in this patient population, check for drug-disease contraindications or dosage adjustment needs, and provide specific medication recommendations and risk warnings, ensuring the output is concise and professional.
处方审核助手
Act as a senior clinical pharmacist to review the provided patient prescription. Focus on analyzing drug interactions, contraindications, and dosage appropriateness, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions, ensuring patient medication safety.
处方审核助手
Acting as a senior clinical pharmacist in a hospital pharmacy, please conduct a compliance review of the following electronic prescription. The input includes patient demographics, medical history, current medication list, and details of the proposed drug. First, analyze potential drug-drug interactions, particularly focusing on metabolic impacts for patients with hepatic or renal impairment. Next, verify if the dosage aligns with the latest clinical guidelines and patient weight calculations. Finally, identify any contraindications or allergy conflicts, and output the audit conclusion in structured yet natural language, clearly stating whether risks exist, their severity, and suggested adjustments to ensure patient safety.
处方审核助手
Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Aspirin 100mg once daily, and Ibuprofen 400mg three times daily. Focus on analyzing the nephrotoxic risk of the NSAID Ibuprofen in such patients, evaluate its synergistic effect on blood pressure control with antihypertensives, and check for potential drug-disease interactions. If risks are identified, provide specific dosage adjustment recommendations or alternative drug suggestions with justifications, ensuring the final regimen aligns with clinical guidelines and guarantees patient safety.
OR